| Issue | Title | |
| Vol 2004, No 46 (2004) | Yamanouchi and Fujisawa Strive for Global Mega-Player Status with Merger Agreement | Abstract pdf |
| Business Review Editor | ||
| Vol 2004, No 49 (2004) | Yamanouchi and Pfizer Streamline Partnership for Japan | Abstract pdf |
| Business Review Editor | ||
| Vol 2004, No 43 (2004) | Yamanouchi to Market Aventis’ Peptic Ulcer Drug Amidst Merger Talks | Abstract pdf |
| Business Review Editor | ||
| Vol 2008, No 93 (2008) | Yondelis (Trabectedin) | Abstract pdf |
| Business Review Editor | ||
| Vol 2021, No 7 (2021) | Zai Lab Forms Another Oncology Partnership with MacroGenics | Abstract pdf html |
| Swati Sharan | ||
| Vol 2021, No 6 (2021) | Zai Lab Strengthens Oncology Pipeline with US$ 338 M Mirati Alliance in Greater China | Abstract html pdf |
| Swati Sharan & Michelle Liu | ||
| Vol 2022, No 9 (2022) | Zealand Pharma Signs Licensing Agreement with Novo Nordisk for Zegalogue® | Abstract pdf html |
| Ayush Saxena | ||
| Vol 2003, No 37 (2003) | Zimmer Trumps Smith & Nephew in Bid for Swiss Orthopedics Company | Abstract pdf |
| Business Review Editor | ||
| Vol 2002, No 30 (2002) | Zonagen to Merge with Lavipharm | Abstract pdf |
| Business Review Editor | ||
| Vol 2009, No 3 (2009) | Zydus Cadila and Lilly Enter US$300 M Research Pact | Abstract |
| Taskin Ahmed | ||
| Vol 2008, No 102 (2008) | Zydus Cadila Enters Vaccines Market by Acquiring Etna Biotech | Abstract pdf html |
| Taskin Ahmed | ||
| Vol 2009, No 1 (2009) | ZymoGenetics in Blockbuster Deal with BMS | Abstract pdf html |
| Taskin Ahmed | ||
| Vol 2009, No 6 (2009) | ZymoGenetics Licenses Non-Core Assets to Seattle Life Sciences | Abstract |
| Taskin Ahmed | ||
| 2601 - 2613 of 2613 Items | << < 22 23 24 25 26 27 | |